Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Difference between revisions of "Burtscher 2020 iScience"

From Bioblast
Β 
Line 1: Line 1:
{{Publication
{{Publication
|title=Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP (2020) Mitochondria - in the crossfire of SARS-CoV-2 and immunity. iScience [Epub ahead of print].
|title=Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP (2020) Mitochondria - in the crossfire of SARS-CoV-2 and immunity. iScience 23:101631.
|info=[https://www.ncbi.nlm.nih.gov/pubmed/33015593 PMID: 33015593 Open Access]
|info=[https://www.ncbi.nlm.nih.gov/pubmed/33015593 PMID: 33015593 Open Access]
|authors=Burtscher Johannes, Cappellano Giuseppe, Omori Akiko, Koshiba Takumi, Millet Gregoire P
|authors=Burtscher Johannes, Cappellano Giuseppe, Omori Akiko, Koshiba Takumi, Millet Gregoire P

Latest revision as of 22:42, 29 October 2020

Publications in the MiPMap
Burtscher J, Cappellano G, Omori A, Koshiba T, Millet GP (2020) Mitochondria - in the crossfire of SARS-CoV-2 and immunity. iScience 23:101631.

Β» PMID: 33015593 Open Access

Burtscher Johannes, Cappellano Giuseppe, Omori Akiko, Koshiba Takumi, Millet Gregoire P (2020) iScience

Abstract: The pathophysiology, immune reaction, differential vulnerability of different population groups and viral host immune system evasion strategies of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) infection are not yet well understood. Here, we reviewed the multitude of known strategies of coronaviruses and other viruses to usurp mitochondria-associated mechanisms involved in the host innate immune response and put them in context with the current knowledge on SARS-CoV-2. We argue that maintenance of mitochondrial integrity is essential for adequate innate immune system responses and to blunt mitochondrial modulation by SARS-CoV-2. Mitochondrial health thus may determine differential vulnerabilities to SARS-CoV-2 infection rendering markers of mitochondrial functions promising potential biomarkers for SARS-CoV-2 infection risk and severity of outcome. Current knowledge gaps on our understanding of mitochondrial involvement in SARS-CoV-2 infection, life-style and pharmacological strategies to improve mitochondrial integrity and potential reciprocal interactions with chronic and age-related diseases, e.g. Parkinson's Disease, are pointed out.

Β© 2020 The Author(s).

β€’ Bioblast editor: Plangger M β€’ O2k-Network Lab: CH Lausanne Place N


Labels: MiParea: mt-Medicine  Pathology: Infectious 






2020-10